Overview

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether dapivirine gel 4789 is safe for daily use by healthy women in South Africa.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
International Partnership for Microbicides, Inc.
Treatments:
Dapivirine